Stopping primary prophylaxis in HIV-1-infected patients at high risk of toxoplasma encephalitis. Swiss HIV Cohort Study
Details
Serval ID
serval:BIB_5D6AF3410C19
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
Title
Stopping primary prophylaxis in HIV-1-infected patients at high risk of toxoplasma encephalitis. Swiss HIV Cohort Study
Journal
Lancet
ISSN
0140-6736 (Print)
Publication state
Published
Issued date
06/2000
Volume
355
Number
9222
Pages
2217-8
Notes
Letter
Multicenter Study
Research Support, Non-U.S. Gov't --- Old month value: Jun 24
Multicenter Study
Research Support, Non-U.S. Gov't --- Old month value: Jun 24
Abstract
Discontinuation of primary prophylaxis against toxoplasma encephalitis was studied in 199 HIV-1-infected patients on antiretroviral combination treatment who had experienced a sustained increase in their CD4 count. During a follow-up of 272 person-years, no cases of toxoplasma encephalitis arose.
Keywords
AIDS-Related Opportunistic Infections/*prevention & control
Adult
Anti-HIV Agents/therapeutic use
Anti-Infective Agents/therapeutic use
CD4 Lymphocyte Count
Chemoprevention
Cohort Studies
Confidence Intervals
Encephalitis/*parasitology/prevention & control
Female
Follow-Up Studies
*HIV Infections/drug therapy
*Hiv-1
Humans
Male
Middle Aged
Prospective Studies
Switzerland
Toxoplasmosis, Cerebral/*prevention & control
Pubmed
Web of science
Create date
25/01/2008 15:46
Last modification date
20/08/2019 15:15
Usage data
